Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 2Thrombocythemia, Essential 1Stomach Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Patient Outcome Assessment 1Pancreatic Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia 1Gastrointestinal Neoplasms 1ESCC 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anemia, Refractory, with Excess of Blasts 1Adenocarcinoma 1

Interventions

fludarabine phosphate 20Peripheral Blood Stem Cell Transplantation 20Cyclophosphamide 17Busulfan 16ruxolitinib 14Tacrolimus 12Whole-Body Irradiation 9Mycophenolic Acid 9Methotrexate 8Antilymphocyte Serum 8Cyclosporine 7peginterferon alfa-2a 6Hydroxyurea 6Filgrastim 6Etoposide 6Aspirin 6fludarabine 5Prednisone 5Melphalan 5Imatinib Mesylate 5Cytarabine 5Decitabine 4pomalidomide 3givinostat hydrochloride 3givinostat 3Topotecan 3Thiotepa 3Radiotherapy 3Lenalidomide 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Polycythemia Vera × Induction Chemotherapy × Clear all
NCT02084563 2016-11-08

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Hospital Israelita Albert Einstein

Phase 2 Completed
455 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡